Production (Stage)
Tenax Therapeutics, Inc.
TENX
$6.07
$0.020.33%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -10.41M | -6.27M | -3.96M | -3.58M | -3.80M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.14M | 969.10K | 20.90K | 31.30K | 127.00K |
| Change in Net Operating Assets | -701.00K | 1.77M | 852.30K | 513.30K | -1.49M |
| Cash from Operations | -6.97M | -3.53M | -3.09M | -3.03M | -5.17M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -100.00 | -278.80K | -134.40K | -88.00K |
| Issuance of Common Stock | 347.00K | -- | 91.95M | 0.00 | 1.00K |
| Repurchase of Common Stock | -- | -100.24M | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 23.22M | 100.30M | 340.60K | 0.00 | 8.01M |
| Cash from Financing | 23.56M | 67.20K | 92.01M | -134.40K | 7.92M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 16.60M | -3.46M | 88.93M | -3.17M | 2.76M |